Moura Brenda, Aimo Alberto, Al-Mohammad Abdallah, Flammer Andreas, Barberis Vassilis, Bayes-Genis Antoni, Brunner-La Rocca Hans-Peter, Fontes-Carvalho Ricardo, Grapsa Julia, Hülsmann Martin, Ibrahim Nasrien, Knackstedt Christian, Januzzi James L, Lapinskas Tomas, Sarrias Axel, Matskeplishvili Simon, Meijers Wouter C, Messroghli Daniel, Mueller Christian, Pavo Noemi, Simonavičius Justas, Teske Arco J, van Kimmenade Roland, Seferovic Petar, Coats Andrew J S, Emdin Michele, Richards A Mark
Faculty of Medicine, University of Porto, Porto, Portugal.
Cardiology Department, Porto Armed Forces Hospital, Porto, Portugal.
Eur J Heart Fail. 2021 Oct;23(10):1577-1596. doi: 10.1002/ejhf.2339. Epub 2021 Sep 14.
Circulating biomarkers and imaging techniques provide independent and complementary information to guide management of heart failure (HF). This consensus document by the Heart Failure Association (HFA) of the European Society of Cardiology (ESC) presents current evidence-based indications relevant to integration of imaging techniques and biomarkers in HF. The document first focuses on application of circulating biomarkers together with imaging findings, in the broad domains of screening, diagnosis, risk stratification, guidance of treatment and monitoring, and then discusses specific challenging settings. In each section we crystallize clinically relevant recommendations and identify directions for future research. The target readership of this document includes cardiologists, internal medicine specialists and other clinicians dealing with HF patients.
循环生物标志物和成像技术为指导心力衰竭(HF)的管理提供了独立且互补的信息。欧洲心脏病学会(ESC)心力衰竭协会(HFA)的这份共识文件介绍了与HF中成像技术和生物标志物整合相关的当前循证指征。该文件首先关注循环生物标志物与成像结果在筛查、诊断、风险分层、治疗指导和监测等广泛领域的联合应用,然后讨论了特定的具有挑战性的情况。在每个部分中,我们梳理出临床相关建议并确定未来研究方向。本文档的目标读者包括心脏病专家、内科专家和其他治疗HF患者的临床医生。